Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Published:2017-11 Issue:11 Volume:6 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Bossard Matthias¹²,Granger Christopher B.³,Tanguay Jean‐Francois⁴,Montalescot Gilles⁵,Faxon David P.⁶,Jolly Sanjit S.¹,Widimsky Petr⁷,Niemela Kari⁸,Steg Philippe Gabriel⁹¹⁰,Natarajan Madhu K.¹,Gao Peggy¹,Fox Keith A. A.¹¹,Yusuf Salim¹,Mehta Shamir R.¹

Affiliation:

1. Population Health Research Institute, McMaster University Hamilton Health Sciences, East Hamilton, Ontario, Canada

2. Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland

3. Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC

4. Montreal Heart Institute, Université de Montréal, Montréal, Quebec, Canada

5. Université Sorbonne‐Paris 6, ACTION group, Institute of Cardiology, Centre Hospitalier Universitaire Pitié‐Salpêtrière (AP‐HP), Paris, France

6. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard University, Boston, MA

7. Cardiocenter, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic

8. Heart Center, Tampere University Hospital, Tampere, Finland

9. Cardiology Department, Hôpital Bichat‐Claude Bernard, Paris, France

10. Université Paris, Paris, France

11. Centre for Cardiovascular Science, Royal Infirmary, University of Edinburgh, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012

2. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the “smoker's paradox” from the gusto‐i trial, with angiographic insights. Global utilization of streptokinase and tissue‐plasminogen activator for occluded coronary arteries;Barbash GI;J Am Coll Cardiol,1995

3. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli thrombolytic national survey)

4. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction—The smoker's paradox revisited

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker’s paradox;Pathology - Research and Practice;2024-05

2. The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance;Journal of Clinical Laboratory Analysis;2022-09-10

3. No Paradoxical Effect of Smoking Status on Recurrent Cardiovascular Events in Patients Following Percutaneous Coronary Intervention: Thai PCI Registry;Frontiers in Cardiovascular Medicine;2022-05-27

4. The impact of cigarette smoking in predicting stroke using CHADS2 and CHA2DS2-VASc schemas;Neurological Sciences;2020-06-22

5. Impact of smoking on platelet function of ticagrelor versus clopidogrel in minor stroke or transient ischaemic attack;European Journal of Neurology;2020-03-08